Back to top

Image: Bigstock

Company News for July 12, 2017

Read MoreHide Full Article

•    Shares of Amicus Therapeutics, Inc. (FOLD - Free Report) soared 25.9% following news that the company has received permission from the U.S. Food and Drug Administration to submit an experimental drug for approval

•    Simulations Plus, Inc.’s (SLP - Free Report) shares gained 6.2% after posting fiscal third-quarter revenues of $6.75 million, outpacing the Zacks Consensus Estimate of $6 million

•    Shares of Arena Pharmaceuticals, Inc. surged 41.4% following positive mid-stage trial results for its drug ralinepag

•    Evogene Ltd’s (EVGN - Free Report) shares surged 10.8% after the company declared that it has reached an important stage in crop disease collaboration with Monsanto Company
 


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Simulations Plus, Inc. (SLP) - free report >>

Amicus Therapeutics, Inc. (FOLD) - free report >>

Evogene Ltd. (EVGN) - free report >>